Join
Live feed
·
PRReleasevia Quantisnow
Ethos Technologies Inc. logo

aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis

ByQuantisnow·Wall Street's wire, on your screen.
LIFE· Ethos Technologies Inc.
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIFE (Ethos Technologies Inc.) and more on Quantisnow.